Аннотация
Between March 2003 and February 2005 cell therapy with mononuclear bone marrow cells (MBMC) was used in 38 and 4 patients with ischemic heart disease and dilated cardiomyopathy, respectively. Intracardiac administration of MBMC (87±12 millions) was carried out during coronary artery bypass surgery and/or left ventricular aneurism resection (n=25) or in cardiac catheterization laboratory (n=17). For verification of cells fixation they were labeled with "Ceretec" 99mTc-HMPAO. Accumulation of labeled cells after 24 hours was 1.6±0.001%. After 6 months parameters of intracardiac hemodynamics and transitory myocardial perfusion defects improved significantly in all patients with ischemic heart disease.
Язык оригинала | Английский |
---|---|
Страницы (с-по) | 10-14 |
Число страниц | 5 |
Журнал | Kardiologiya |
Том | 46 |
Номер выпуска | 7 |
Состояние | Опубликовано - 2006 |
Опубликовано для внешнего пользования | Да |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine